Article
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replication.
Liver international : official journal of the International Association for the Study of the Liver - 1 Oct 2009
Li Chang-Zheng, Kato Naoya, Chang Jin-Hai, Muroyama Ryosuke, Shao Run-Xuan, Dharel Narayan, Sermsathanasawadi Radsamee, Kawabe Takao, Omata Masao
Abstract excerpt
BACKGROUND: Progression of disease after hepatitis C virus (HCV) infection differs among individuals, indicating a possibility of participation of host genetic factors. 2'-5'-oligoadenylate synthetase 1 (OAS-1), an important component of the innate immune system, has an antiviral function, and may therefore have a certain relationship with progression of disease. AIM: To evaluate single nucleotide polymorphisms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
